Observational studyMedicina (Kaunas, Lithuania)2025

Real-World Data of First 12-Months of Ofatumumab Treatment in Multiple Sclerosis Patients-A Multicenter Experience from Tertiary Referral Centers.

Weronika Galus et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.